Zobrazeno 1 - 10
of 352
pro vyhledávání: '"Patrice Chevallier"'
Autor:
Micha Srour, Tamim Alsuliman, Julien Labreuche, Claude-Eric Bulabois, Patrice Chevallier, Etienne Daguindau, Edouard Forcade, Sylvie François, Gaelle Guillerm, Valerie Coiteux, Pascal Turlure, Yves Beguin, Ibrahim Yakoub-Agha, Leonardo Magro
Publikováno v:
Bone Marrow Transplantation. 58:401-406
Autor:
Paul Chauvet, Annalisa Paviglianiti, Myriam Labopin, Hélène Labussière, Nicolas Boissel, Marie Robin, Natacha Maillard, Marie Ouachée-Chardin, Edouard Forcade, Xavier Poiré, Sylvain Chantepie, Anne Huynh, Claude Eric Bulabois, Mathieu Leclerc, Sébastien Maury, Patrice Chevallier, Thomas Cluzeau, Jean-Baptiste Mear, Jérôme Cornillon, Karin Bilger, Célestine Simand, Yves Beguin, Marie-Thérèse Rubio, Ibrahim Yakoub-Agha, Eolia Brissot
Publikováno v:
Bone Marrow Transplantation. 58:72-79
Relapsed B-cell acute lymphoblastic leukemia (B-ALL) after allogeneic stem cell transplantation (allo-HCT) still represents a major concern with poor outcomes. The aim of this study is to compare the efficacy and safety of blinatumomab and donor lymp
Autor:
Meral Beksac, Simona Iacobelli, Linda Koster, Jan Cornelissen, Laimonas Griskevicius, Neil K. Rabin, Anne Marie Stoppa, Ellen Meijer, Jean-Baptiste Mear, Sacha Zeerleder, Jiri Mayer, Roland Fenk, Nathalie Fegueux, Patrice Chevallier, Eva Konirova, John A. Snowden, Monika Engelhardt, Kim Orchard, Cyrille Hulin, Nicolaas Schaap, Claudia Sossa, Ahmet Elmaagacli, Donal P. McLornan, Patrick J. Hayden, Stefan Schönland, Ibrahim Yakoub-Agha
Publikováno v:
Bone Marrow Transplantation. Nature Publishing Group
Beksac, M, Iacobelli, S, Koster, L, Cornelissen, J, Griskevicius, L, Rabin, N K, Stoppa, A M, Meijer, E, Mear, J-B, Zeerleder, S, Mayer, J, Fenk, R, Fegueux, N, Chevallier, P, Konirova, E, Snowden, J A, Engelhardt, M, Orchard, K, Hulin, C, Schaap, N, Sossa, C, Elmaagacli, A, McLornan, D P, Hayden, P J, Schönland, S & Yakoub-Agha, I 2023, ' An early post-transplant relapse prediction score in multiple myeloma : a large cohort study from the chronic malignancies working party of EBMT ', Bone Marrow Transplantation . https://doi.org/10.1038/s41409-023-01999-1
Beksac, M, Iacobelli, S, Koster, L, Cornelissen, J, Griskevicius, L, Rabin, N K, Stoppa, A M, Meijer, E, Mear, J-B, Zeerleder, S, Mayer, J, Fenk, R, Fegueux, N, Chevallier, P, Konirova, E, Snowden, J A, Engelhardt, M, Orchard, K, Hulin, C, Schaap, N, Sossa, C, Elmaagacli, A, McLornan, D P, Hayden, P J, Schönland, S & Yakoub-Agha, I 2023, ' An early post-transplant relapse prediction score in multiple myeloma : a large cohort study from the chronic malignancies working party of EBMT ', Bone Marrow Transplantation . https://doi.org/10.1038/s41409-023-01999-1
Early relapse (ER) following Autologous Hematopoietic Cell Transplantation (AHCT) confers a poor prognosis. We therefore developed a novel scoring system to predict ER. A total of 14,367 AHCT-1 patients were transplanted between 2014 and 2019, and we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43fb4c1e1c34a89ee68a56aa14fdcf34
https://pure.eur.nl/en/publications/a0b2dfef-0ebe-45fa-8fa3-a0858599ba8f
https://pure.eur.nl/en/publications/a0b2dfef-0ebe-45fa-8fa3-a0858599ba8f
Autor:
Klaus Hirschbühl, Myriam Labopin, Emmanuelle Polge, Didier Blaise, Jean Henri Bourhis, Gerard Socié, Edouard Forcade, Ibrahim Yakoub-Agha, Hélène Labussière-Wallet, Wolfgang Bethge, Patrice Chevallier, Sarah Bonnet, Matthias Stelljes, Alexandros Spyridonidis, Zinaida Peric, Eolia Brissot, Bipin Savani, Sebastian Giebel, Christoph Schmid, Fabio Ciceri, Arnon Nagler, Mohamad Mohty
Publikováno v:
Bone Marrow Transplantation.
Allogeneic hematopoietic cell transplantation is a potentially curative treatment in high-risk acute lymphoblastic leukemia (ALL). Conditioning regimens based on ≥12 Gray total body irradiation (TBI) represent the current standard in patients ≤45
Autor:
Olivier Tournilhac, Michel van Gelder, Dirk-Jan Eikema, Nienke Zinger, Peter Dreger, Martin Bornhäuser, Vladan Vucinic, Christof Scheid, Jan J. Cornelissen, Thomas Schroeder, Pavel Jindra, Henrik Sengeloev, Stephanie Nguyen Quoc, Matthias Stelljes, Igor Wolfgang Blau, Jiri Mayer, Shankara Paneesha, Patrice Chevallier, Edouard Forcade, Nicolaus Kröger, Didier Blaise, John Gribben, Bendt Nielsen, Jan-Erik Johansson, Charalampia Kyriakou, Yves Beguin, Pietro Pioltelli, Antònia Sampol, Donal P. McLornan, Johannes Schetelig, Patrick J. Hayden, Ibrahim Yakoub-Agha
Publikováno v:
Bone Marrow Transplantation, 58(6), 621-624. Nature Publishing Group
Allogeneic transplantation (allo-HCT) is a curative treatment in CLL whose efficacy including the most severe forms had led to the 2006 EBMT recommendations. The advent after 2014 of targeted therapies has revolutionized CLL management, allowing prol
Autor:
Maxime Jullien, Amandine Le Bourgeois, Pierre Peterlin, Alice Garnier, Thierry Guillaume, Marie C. Béné, Patrice Chevallier
Publikováno v:
Bone Marrow Transplantation.
Autor:
Maria Elkababri, Tereza Coman, Cécile Pochon, Quentin Cabrera, Asmaa Quessar, Mhamed Harif, Faty Hamzy, Mohamed Amine Bekadja, Patrice Chevallier, Amal Laamiri, Ibrahim Yakoub-Agha, Nabil Yafour
Publikováno v:
Bulletin du Cancer. 108:S10-S19
Hematopoietic cell transplantation (HCT) is the curative treatment for many malignant and non-malignant blood disorders and some solid cancers. However, transplant procedures are considered tertiary level care requiring a high degree of technicality
Autor:
Eléonore Kaphan, François Bettega, Edouard Forcade, Hélène Labussière-Wallet, Nathalie Fegueux, Marie Robin, Régis Peffault De Latour, Anne Huynh, Léopoldine Lapierre, Ana Berceanu, Ambroise Marcais, Pierre-Edouard Debureaux, Nicolas Vanlangendonck, Claude-Eric Bulabois, Leonardo Magro, Adrien Daniel, Jean Galtier, Bruno Lioure, Patrice Chevallier, Chloé Antier, Michael Loschi, Gaelle Guillerm, Jean-Baptiste Mear, Sylvain Chantepie, Jérome Cornillon, Gaelle Rey, Xavier Poire, Ali Bazarbachi, Marie-Thérèse Rubio, Nathalie Contentin, Corentin Orvain, Rémy Dulery, Jacques Olivier Bay, Carolyne Croizier, Yves Beguin, Aude Charbonnier, Caroline Skrzypczak, Déborah Desmier, Alban Villate, Martin Carré, Anne Thiebaut-Bertrand
Publikováno v:
Transplantation and Cellular Therapy. 29:362.e1-362.e12
Autor:
Hélène Labussière-Wallet, Annalisa Ruggeri, Edouard Forcade, Jorge Sierra, Myriam Labopin, Deborah Desmier, Frédéric Baron, Nathalie Fegueux, Mohamad Mohty, Didier Blaise, Jan J. Cornelissen, Thomas Cluzeau, Jennifer Byrne, Patrice Chevallier, Arnon Nagler
Publikováno v:
Bone Marrow Transplantation, 57(10), 1514-1519. Nature Publishing Group
BONE MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
BONE MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Background: Achieving a first complete remission (CR1) is an important prognostic factor for transplantation outcome. However, there are no data in the setting of cord blood transplantation (CBT) indicating whether the number of induction courses (1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42b43127bd8f90af1b23e872a8f8b654
https://pure.eur.nl/en/publications/f3bb2668-f6e4-4fd5-8761-91d9f0537507
https://pure.eur.nl/en/publications/f3bb2668-f6e4-4fd5-8761-91d9f0537507
Autor:
Mark A. Schroeder, Steven M. Devine, Yi-Bin Chen, Andrejus Parfionovas, Yngvar Fløisand, Syed Quadri, Dominik Selleslag, Chunlin Chen, Ibrahim Yakoub-Agha, Patrice Chevallier, Mona Akbari, Mohamad Mohty, Johan Jansson, Anne S. Renteria
Publikováno v:
Bone Marrow Transplantation
Bone Marrow Transplantation, In press, ⟨10.1038/s41409-021-01356-0⟩
Bone Marrow Transplantation, Nature Publishing Group, In press, ⟨10.1038/s41409-021-01356-0⟩
Bone Marrow Transplantation, In press, ⟨10.1038/s41409-021-01356-0⟩
Bone Marrow Transplantation, Nature Publishing Group, In press, ⟨10.1038/s41409-021-01356-0⟩
Steroid-refractory (SR) acute graft-versus-host disease (aGvHD) remains a significant complication after allogeneic hematopoietic cell transplantation. Systemic corticosteroids are first-line therapy for aGvHD, but apart from ruxolitinib, there are n